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Abstract
Background: Making evidence-based decisions often requires comparison of two or more options. Research-based
evidence may exist which quantifies how likely the outcomes are for each option. Understanding these numeric
estimates improves patients’ risk perception and leads to better informed decision making. This paper summarises
current “best practices” in communication of evidence-based numeric outcomes for developers of patient decision
aids (PtDAs) and other health communication tools.
Method: An expert consensus group of fourteen researchers from North America, Europe, and Australasia
identified eleven main issues in risk communication. Two experts for each issue wrote a “state of the art” summary
of best evidence, drawing on the PtDA, health, psychological, and broader scientific literature. In addition,
commonly used terms were defined and a set of guiding principles and key messages derived from the results.
Results: The eleven key components of risk communication were: 1) Presenting the chance an event will occur;
2) Presenting changes in numeric outcomes; 3) Outcome estimates for test and screening decisions; 4) Numeric
estimates in context and with evaluative labels; 5) Conveying uncertainty; 6) Visual formats; 7) Tailoring estimates;
8) Formats for understanding outcomes over time; 9) Narrative methods for conveying the chance of an event;
10) Important skills for understanding numerical estimates; and 11) Interactive web-based formats. Guiding
principles from the evidence summaries advise that risk communication formats should reflect the task required of
the user, should always define a relevant reference class (i.e., denominator) over time, should aim to use a
consistent format throughout documents, should avoid “1 in x” formats and variable denominators, consider the
magnitude of numbers used and the possibility of format bias, and should take into account the numeracy and
graph literacy of the audience.
Conclusion: A substantial and rapidly expanding evidence base exists for risk communication. Developers of tools
to facilitate evidence-based decision making should apply these principles to improve the quality of risk
communication in practice.
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Background
Health decisions often require patients and clinicians to
compare and choose among two or more options. The
chosen path may bring with it a number of benefits and
harms for the individual patient. Informing these choices
with the best available evidence from scientific research
is desirable and, where available, outcomes should be
provided that have been quantified through research
[1,2]. For both written and verbal information, patients
have a more accurate understanding of risk if probabilis-
tic information is presented as numbers rather than
words, even though some may prefer receiving words [3].
Patient decision aids (PtDAs) can be an effective strat-
egy for integrating research evidence with patient values
and other factors to facilitate greater patient involve-
ment, improve decision quality, and increase knowledge
about decision options [4]. Sixteen out of the 86 trials
in the Cochrane Collaboration review of PtDAs for
treatment and screening decisions measured the effects
of including numeric estimates on patients’ understand-
ing [4]. Presenting numeric estimates within a PtDA sig-
nificantly improved the accuracy of risk comprehension
(RR 1.7, 95% CI 1.5 to 2.1), compared with not receiving
numeric estimates, with larger effect size when estimates
were presented as numbers, versus describing them in
words.
A theoretical rationale for evaluating patient decision
aids on this quality standard
The argument outlined above serves, in effect, as a
broad justification for considering “presenting quantita-
tive information about decision outcomes in PtDAs” as
an important quality standard when evaluating a PtDA.
However, although the inclusion of numeric risk esti-
mates in PtDAs appears to be an effective strategy for
promoting informed decision making, many important
questions about risk communication remain. Exactly
how should numeric risk estimates be represented in
order to maximize patient understanding? What are the
essential elements of effective risk communication, and
does empirical evidence support particular methods or
“best practices” for representing and communicating
numeric risk estimates using PtDAs?
Purpose
While we were updating the International Patient Deci-
sion Aid Standards (IPDAS) Collaboration’s original
Background Document, our working group developed a
wide-ranging review of current knowledge in the field of
risk communication, including relevant evidence from
the broader science and social science literature. The
purpose of this paper is to summarize our insights into
the “state of the science” about the presentation of
quantitative information about decision outcomes, and,
in doing so, to focus on communication issues that are
likely not only to have practical application in the devel-
opment of PtDAs but also to inform the further devel-
opment of the quality standards.
Empirical evidence
Method
Since the literature on risk communication is so vast, this
evidence summary was developed by expert consensus.
Our focus was to provide clear guidance for PtDA develo-
pers regarding design issues for which substantial research
evidence exists and to identify those design problems
remaining to be resolved. Thus, since the purpose of this
review was to provide guidance about risk communication
generally, not to answer a focussed question, a systematic
review was not feasible or appropriate.
The expert international working group was formed
by inviting key authors in the field. The fourteen indivi-
duals who agreed to participate were drawn from North
America, Europe and Australasia. Several had partici-
pated in writing the first version of this material in the
IPDAS Collaboration’s 2005 Background Document.. As
a first step, members of the group identified major
issues in communicating quantitative information for
PtDA development. This was achieved through an itera-
tive and interactive online discussion process and drew
heavily upon the combined expertise of the authors.
Each member of the working group assisted in draft-
ing at least two of the issue-focused sections and
worked closely with at least one other author in this
task. Each team drew upon their collective expertise to
define current best practices for communicating prob-
abilities in PtDAs and to provide illustrative research
findings in support of their recommendations.
The entire working group then provided input and peer
review to the full draft document, resolving disagree-
ments through additional debate and discussion to reach
consensus. The group also took time to clarify a number
of definitions to address some of the confusion arising
from terminology used in the various risk communica-
tion domains. These definitions are listed in Table 1.
Results
We identified eleven major risk communication issues
involved in the presentation of probabilities and related
risk information: 1) Presenting the chance an event will
occur; 2) Presenting changes in numeric outcomes; 3)
Outcome estimates for test and screening decisions; 4)
Numeric estimates in context and with evaluative labels;
5) Conveying uncertainty; 6) Visual formats; 7) Tailoring
estimates; 8) Formats for understanding outcomes over
time; 9) Narrative methods for conveying the chance of an
event; 10) Important skills for understanding numerical
estimates; and 11) Interactive web-based formats.
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Presenting the chance an event will occur
In Figure 1, we outline some guiding principles for
including numeric estimates in decision aids. Below, we
discuss these principles in detail.
Suitable formats for presenting numeric chances
depend on the nature of the task [5]. When the task is
to present the chance of a single event, simple frequency
formats that include a number and time interval (such
Table 1 Terms and definitions in risk communication
Term Definition
Simple frequency format Expresses the event rate as an integer with an appropriate denominator (e.g. x in 100)
Simple percentage format Expresses the event rate as a percentage (e.g. x%)
Natural frequency format The term ‘natural frequencies’ was proposed for estimating the probability arising from a joint occurrence of
events (e.g. the probability of having breast cancer given an abnormal mammography result). Natural
frequencies preserve the base rate of the outcome (e.g. breast cancer) and report the ‘actual’ or ‘natural’
number of people having a particular outcome (e.g. having a positive test result). An example would be “Out of
every 10,000 people, 30 have colorectal cancer. Of these, 15 will have a positive haemoccult test. Out of the
remaining 9970 people without colorectal cancer, 300 will still test positive. How many of those who test
positive actually have colorectal cancer? Answer: 15 out of 315”
Conditional probabilities An alternative representation of this information is the conditional probability format. For example: “The
probability of having colorectal cancer is .003%. Of people who have the cancer, 50% get a positive test result.
Of people who do not have cancer, 3% will nevertheless test positive. What is the probability that a person
who tests positive has colorectal cancer? Answer: 4.8%”.
Bayesian reasoning Infers the post-probability of outcome from the prior probability and a likelihood function.
Tailored health communication Refers to providing information to a person based on characteristics that are unique to that person. It is
assumed that tailored messages are perceived as more relevant to an individual and are therefore better
processed and understood. Tailoring information using an individual’s specific risk factors might likewise
increase people’s involvement with the information and lead to a better understanding.
Aleatory uncertainty It is concerned with the randomness or indeterminacy of future events.
Epistemic uncertainty On the other hand, this is the lack of knowledge needed to predict future outcomes, also known as “ambiguity”
and is concerned with the lack of reliability, credibility, or adequacy of risk information. A primary example is
imprecision in risk estimates which are typically expressed by confidence intervals.
Pictographs (sometimes called
icon arrays)
They are visual graphic display formats which aim to represent the size of both the numerator and
denominator in the one diagram. In other words, they show the part-whole relationship. Examples include
systematic ovals, 100 face or human figure diagrams and displays where event icons are scattered rather than
grouped.
Numeracy It is the ability to understand and apply mathematical concepts.
Patient narratives Stories, also called testimonials, about individuals’ experiences or health outcomes, usually told from a first-
person perspective.
Figure 1 Guiding principles for including numeric estimates in decision aids
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as “Every year 10 in 100 people with pre-diabetes
develop diabetes”), or simple percentage formats (such
as “Every year 10% of those with pre-diabetes will
develop diabetes”) are more transparent than formats
such as “The chance of developing diabetes is 10%”. The
last statement is problematic because it does not specify
the “denominator” (i.e., the reference class, as in, for
example, “10% of all pre-diabetics in one year”). Without
a clear description of to whom this estimate refers, peo-
ple might impose their own erroneous interpretations
such as “I only have a 10% chance of developing dia-
betes in my lifetime” [6]. Similarly, when patients who
take fluoxetine for mild depression hear from their doc-
tor that there is a “30-50% chance of developing a sexual
problem such as impotence or loss of sexual interest,”
some may think this means they will have problems in
30% of their own sexual encounters. The “denominator”
or reference class used by the doctor is “patients on
fluoxetine”, but the denominator used by the patient is
“their own sexual encounters” [7].
There is also some evidence that risks presented in
simple frequencies are perceived as higher than when
they are presented in their equivalent percentage value,
especially in patients with lower numeracy [8] and (pos-
sibly) when smaller percentages are presented [9]. Given
this potential format bias, one should be careful when
comparing results of studies that have used different for-
mats (percentages or simple frequencies). Formats
should aim to be consistent throughout a PtDA (see
below). Providing simple frequency AND percentage
appears to add no advantage [9], and there is strong evi-
dence that “1 in x” formats with variable denominators
are more difficult to understand and elevate risk percep-
tions[10,11]. They should be avoided for all tasks.
1. In summary, it is most important when presenting
the chance of a single event to clearly define the
denominator or reference class over time. Percent or
simple frequency formats can be used for presenting the
chance of a single event. However, in deciding which
one to use, consider what other information needs to be
presented and what the purpose of the PtDA is, overall,
so there is format consistency throughout. Visual for-
mats may also help to reduce bias (see Formats for
understanding outcomes over time, below).
When the task is to compare the chance of occurrence
of two or more independent events (e.g., the chance of
symptom relief with drug A compared with placebo), for-
mats that express the chance of an event using one num-
ber, such as percentages, work better than simple
frequencies involving more than one number, such as 1
in 100 [9]. If using simple frequencies such as 1 in 100,
one should use the same denominator (e.g., 1 in 100 ver-
sus. 2 in 100) as these are easier to compare than fre-
quencies using different denominators (e.g., 1 in 100
versus. 1 in 50) [8,10]. Consistent denominators should
always be used. When choosing the size of the denomina-
tor, smaller numbers (e.g., 100) are easier to understand
and remember than larger numbers (e.g., 10,000) [12].
There has been discussion about whether people find
percentages less than one (e.g., 0.1%) more difficult to
understand than the equivalent simple frequency (e.g., 1
in 1000) [9,10]. However, this problem may reflect diffi-
culty manipulating decimal points (e.g., asking someone
to represent 1 in 1000 as a percentage) rather than a
comprehension problem [9].
In summary, percentages (e.g., x %) may have an
advantage over a simple frequency format (e.g., x in
100) for comparing the chance of occurrence of two or
more independent events. As mentioned before, it
remains important to clearly define the denominator or
‘reference class’ and to aim for a consistent format
throughout the PtDA taking into account the informa-
tion and tasks required.
However, other formats are more suitable for tasks
that involve presenting changes in numeric outcomes
(see Presenting changes in numeric outcomes, below) and
conveying the frequency of joint occurrences of two or
more dependent events, such as the conditional prob-
ability that a person with a positive test result has the
disease (e.g., see Outcome estimates for test and screen-
ing decisions, below).
Presenting changes in numeric outcomes
Most efforts to communicate changes due to interven-
tions (i.e., treatment effects) or across time (e.g.,
improvements of health) use either side-by-side total
risk presentations or difference presentations. Difference
presentations depict the change in risk and can influ-
ence risk perceptions through framing effects. Research
has shown that relative risk presentations (e.g., “30%
lower risk”) tend to magnify risk perceptions and
decrease understanding, compared to absolute risk pre-
sentations (e.g., “the risk is lower by 5 percentage
points”)[13,14]. Number needed to treat (NNT) is some-
times used, but several studies suggest that this format
is poorly understood by patients and may increase the
perceived effect of treatment [15].
A variant is to present incremental risk (absolute risk
increase) after a “baseline” total risk level has been
shown. This approach emphasizes the size of the change
relative to the size of the total risk, and was shown to
lower risk perceptions [16]. Such language (e.g., “5 more
women get…”) was incorporated into the Schwartz et al.
drug facts box [17], and used in decision tools such as
Adjuvant! A PtDA trial suggested that incremental risk
language works best when accompanied by visual dis-
plays [18]. In particular, when the baseline risks are
small, relative risk reductions are perceived to be larger
than absolute risk reductions [13,19,20].
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The framing of outcomes in terms of losses or gains
has been shown to affect people’s choices [21]. Framing
outcomes in terms of potential gains (e.g., the chances of
survival) often generates risk-averse choices, whereas
framing outcomes in terms of potential losses (e.g., the
chances of death) often generates risk-seeking choices. In
clinical situations, the effects of the framing of outcomes
as losses or gains tend to vary across situations [22]; the
variable effect of different frames of risks or rates is due
to emphasizing different aspects of the information.
In summary, when presenting changes in rates, abso-
lute risks should be given either in percentages or sim-
ple frequencies, and if possible along with the absolute
risk increase (or decrease). If frequencies are used, the
denominators should be equal.
Outcome estimates for test and screening decisions
A number of studies and a recent Cochrane Collabora-
tion review [13,23] have shown that natural frequencies
are better than conditional probabilities where events are
connected. It is unclear whether people use Bayesian rea-
soning when making screening decisions, but natural fre-
quency formats are still proposed as the best way to help
people understand these kinds of estimates [24,25]. So, if
a PtDA requires people to calculate the probabilities
associated with jointly occurring events, then a natural
frequency format would be preferable to conditional
probabilities.
However, screening can also be viewed as an “interven-
tion” that has an effect (e.g., reducing death from colorec-
tal cancer). Rates of death from a particular cancer with
and without screening are actually the chances of indepen-
dent events. As noted earlier, there may be some advan-
tage to presenting such information in a percentage
format, but cancer incidence and mortality rates are
usually low in the general population and possible format
biases due to small numbers need to be considered (see
Presenting the chance an event will occur, above). Similarly,
the chance of having a disease if your test result is positive
can be thought of as the “post-test probability”, and some
would suggest this could be calculated on behalf of the
patient and presented in a percentage (1%) or simple fre-
quency format (e.g., 1 in 100). Thus, we recommend that
PtDA developers consider both the nature of the task
required and the other information that needs to be con-
veyed in the same document. It is important to clarify
what the reference class is (e.g., women aged 50 who are
having biennial mammography over 10 years) and to keep
the denominator constant. Once again, “1 in x” formats
should be avoided as they consistently perform worse.
The current IPDAS criteria recommend that screening
PtDAs include estimates of: 1) disease with and without
screening; 2) false positives; and 3) false negatives. The
updated Cochrane Collaboration review of PtDAs
includes 34 trials about screening and test decisions
[26]. Five of these trials measured the accuracy of risk
perception [27-31]. Four of these reported significantly
improved risk perception [27-30] regardless of whether
accurate risk comprehension was measured as numbers
[27,28] or as gist-based risk comprehension in words
[29,30]. Four of the trials also included quantitative esti-
mates in accordance with the IPDAS criteria recommen-
dations. Three of the PtDAs were available and all used
different formats for numerical outcomes. None pro-
vided a head-to-head comparison of formats. Given the
lack of head-to-head format comparison in these trials,
we recommend applying the principles outlined in this
chapter which are based (where possible) on compara-
tive research.
Our review confirms that, in screening PtDAs, the
application of IPDAS criteria about the presentation of
quantitative estimates of screening outcomes improves
the accuracy of risk perceptions.
Numeric estimates in context and with evaluative labels
To help users get perspective on the risk of disease,
PtDA developers should consider including contextual
information when feasible. Context is particularly
important for PtDAs about disease prevention or cancer
screening, in which the benefit is a reduction in disease
specific mortality. One way to provide context is to pro-
vide the chance of death over the next 10 years from
the disease under consideration (where possible accord-
ing to age, smoking status, and other reliable risk factor
information), as well as the chance of dying from other
major causes and from all causes combined [32].
Directly interpreting the meaning of numeric informa-
tion (e.g., telling patients how good or bad a 9% risk is)
can also have a substantial influence on how patients use
that information. This is because patients often do not
understand the meaning of unfamiliar numbers without
additional help, and, without meaning, information tends
not to be used in subsequent decision making. In one
series of studies, providing evaluative labels for numeric
quality-of-care information (e.g., telling decision makers
that the numbers represented “poor” or “excellent” qual-
ity of care) resulted in greater use of this information in
judgments and less reliance on an irrelevant emotional
state among the less numerate [33]. In another study,
evaluative labels for test results (that a patient’s test was
“positive” or “abnormal”) induced larger changes to risk
perceptions and behavioural intentions than did numeric
results alone [34]. The appropriateness of these changes,
however, can be unclear in health contexts, and evalua-
tive labels should be applied carefully.
Conveying uncertainty
Numeric risk estimates ultimately represent evidence-
based, mathematical expressions of uncertainty about
the future. The uncertainty expressed by risk estimates
can be divided into two principal types: 1) “aleatory” or
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first-order uncertainty that reflects the randomness or
indeterminacy of future events, and 2) “epistemic” or
second-order uncertainty, otherwise known as “ambigu-
ity,” that reflects limitations in the reliability, credibility,
or adequacy of risk information. An understanding of
each of these uncertainties is arguably essential for
informed decision making. However, the optimal meth-
ods and outcomes of communicating these uncertainties
to patients are only beginning to be understood [35].
The communication of aleatory uncertainty has been
examined in a small number of studies for both textual
and novel visual methods of representing randomness in
decision support interventions (e.g., icon arrays display-
ing affected individuals in a scattered rather than clus-
tered manner) [36-40]. Available evidence suggests that
these methods have no significant effect on risk percep-
tions, although evidence is lacking regarding their effects
on patients’ understanding of uncertainty. In one study,
however, the communication of randomness was asso-
ciated with greater subjective uncertainty about estimated
risk [41]. The communication of epistemic uncertainty
has been examined in a small number of studies using
confidence intervals to communicate ambiguity in prob-
ability estimates. These studies have shown that commu-
nicating ambiguity has little effect on risk perceptions,
although it increases patient worry [41,42], and these
effects appear to be moderated by representational
method (visual vs. textual) and individual differences
(e.g., dispositional optimism) [39,41]. Evidence is limited
and mixed regarding the extent to which confidence
intervals are understood by patients [43,44] and how they
influence perceptions of the credibility of probability esti-
mates [38,45]. Furthermore, the effects of communicating
both epistemic and aleatory uncertainty on real medical
decisions have not yet been evaluated.
The communication of ambiguity has been evaluated
more fully outside health care. Numerous studies in
behavioural decision research have shown that ambigu-
ity leads to avoidance of decision making and pessimis-
tic risk perceptions and affective responses (worry,
distress) related to choice outcomes—a phenomenon
known as “ambiguity aversion” [46-49]. However, most
studies have examined hypothetical rather than real
decisions.
In summary, evidence on the optimal methods and out-
comes of conveying uncertainty is limited but growing.
Novel representational methods have been developed to
communicate both randomness (aleatory uncertainty) and
ambiguity (epistemic uncertainty); these methods may be
useful to incorporate in PtDAs along with estimates of risk
magnitude. However, the communication of uncertainty
can be psychologically aversive. More research is needed
to determine both the optimal representational methods
and effects of communicating uncertainty on patient per-
ceptions, understanding, and decision making.
Visual formats
Presenting event rates with visual aids such as picto-
graphs (also called icon arrays), bar charts, or flow dia-
grams may aid accurate understanding of probabilities.
Visual displays can help reduce several biases, such as
denominator neglect [50], framing effects [51,52], and
the undue influence of anecdotes [53]. They also can aid
the comprehension of more complicated concepts such
as incremental risk [18]. Graphs that clarify sub-set rela-
tionships (e.g., Venn diagrams, Euler circles) can lead to
better judgements, for instance in Bayesian reasoning
tasks [54,55]. Others believe graphs help, but for differ-
ent reasons [56]. However, there has been some evi-
dence that graphs can affect peoples’ tendencies to
overestimate low probabilities and underestimate high
probabilities – the magnifier effect [57]. Others have
shown the opposite effect (i.e., less overestimation) on
low probabilities and no effect on high [58].
Although the use of visual displays is often recom-
mended as an aid to interpretation for numerical data
[59,60], one important caveat is that people vary in their
ability to extract data and meaning from visual displays.
Galesic & Garcia-Retamero developed a graph literacy
scale that predicts who actually profits from visual dis-
plays [61,62]. For example, visual displays are helpful for
understanding statistical information about health for
people with low numeracy [63,64] yet people who lack
graph literacy may be better off with just numbers [65].
Graphs have sometimes been shown to be better able
to convey the essential aspects of the information (i.e.,
“gross-level information”) [66], bottom line meaning, or
gist [67], whereas numerical representations may better
convey more precise aspects of the information (i.e.,
“detailed-level information” or verbatim) [66,68]. Thus, a
potential weakness of visual displays is that people may
focus more on the pattern of data rather than the pre-
cise values, unless that is the main objective. Further-
more, some graphs are better suited for certain tasks
(e.g., line graphs for trends over time, bar graphs for
comparison across groups) [69,70].
Graph type and formatting have an effect on compre-
hension and behaviour. For instance, one study showed
that the formats that are perceived most accurately and
easily by patients are vertical bars, horizontal bars, and
pictographs. Preferred graphs do not necessarily lead to
better performance than non-preferred graphs. Further-
more, pie charts and pictographs with randomly-distribu-
ted ovals lead to slower and less accurate estimates [66].
Another study showed that different visual formats sup-
ported gist versus verbatim knowledge [68]. Enhancing
accuracy in estimates can be aided by displaying only the
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most crucial elements [71,72], as well as by using icon
arrays (blocks or stick figures) that are arranged as
groups in a block rather than being scattered randomly –
the latter of which is useful to convey the concept
that events (e.g., who is afflicted by disease) occur at
random [73].
Finally, it has been shown that visual aids are most
effective for comprehension when the entire population
at risk is shown rather than only depicting sick people,
for instance [62]. In addition, for conveying small prob-
ability events (e.g., less than 1%), graphical displays (e.g.,
bar charts) that show only the number of people
affected (i.e., foreground information) leads to greater
risk aversion (e.g., greater willingness to pay for an
improved product) than graphic displays that show part-
whole relationship by including the total population or
those not affected) (i.e., background) [74,75]. It is still
unclear whether icon-arrays (which show the part-whole
relationship by including the full denominator) result in
more accurate risk perception than icon-based displays
(which do not have the full denominator).
A recent study in adults with lower education and lit-
eracy [76] found that numerator size was an important
factor when presenting the changes in numeric out-
comes for events out of 1000. Where the outcome is
<100/1000, pictographs were better understood and pro-
cessed more quickly than bar charts, particularly if the
difference between event rates was small. These 1000
denominator pictographs stacked the icons along the
long axis beside a referent scale to support easier read-
ing. However, for more common outcomes ( >100/
1000), bar charts were better, possibly because the icon
arrangement was more complicated. In addition, the
role of shading in processing the part-to-whole relation-
ship of icon arrays is still not well understood.
In summary, visual displays can be a powerful tool to
convey health-related statistical information, especially
for people with higher graphical literacy and among
those who have problems with understanding and apply-
ing numbers. However, some caution is warranted as
visual displays may not be intuitively understood by
everyone. They can be used to represent statistical infor-
mation transparently, but they can also be misused and
misrepresent statistical information [77]. Overall, all
visual aids should be pilot tested for understanding (not
simply preferences), and developers should take care to
avoid using misleading images (such as graphs with mis-
leading scales) or using different scales within the same
PtDA. Finally, the field still needs a more systematic
theoretical understanding of why, when, and for whom
visual displays are effective [69]. Such theories could
help to translate the growing research in graph cogni-
tion and design [78,79] into practical advice for risk
communicators.
Tailoring estimates
To date, the effects of tailoring health risk information
on improving health decision making appear mixed.
Limitations in research quality and heterogeneity in out-
come measures make drawing firm conclusions about
effective strategies difficult. A meta-analytic review
showed that tailored print messages about health have
been effective in stimulating health behaviour change,
but the effect size is small and depends on the variable
that is used for tailoring [80]. The effect of tailoring was
modified by the type, visual layout and length of the
printed material, type of behaviour (more effective for
preventive behaviours) and by demographic factors
[80,81]. Tailored print messages have been shown to
increase uptake of mammography screening [81] and
pap testing [80,81]. A review by Albada et al. showed
that information tailored to an individual’s risk factors
increased risk perception and resulted in better knowl-
edge compared to generic information [82].
Results also are mixed with respect to the effect of tai-
lored health messages on behaviour—for example, on
cancer screening. Tailoring by behavioural constructs
seems to be effective, while there was limited evidence
of the effectiveness of information tailored by risk fac-
tors only, in particular for cancer screening. Bodurtha et
al. also found that a ‘brief (tailored) intervention’ regard-
ing mammography adherence did not change behaviour
[83]. No significant differences existed in mammography
intentions, actual uptake, clinical breast examination, or
self-examination between intervention and control study
arms. However, among those who were most worried,
mammography rates in the intervention group were
higher. Thus, individual characteristics, such as worry
about breast cancer and educational status, may modify
the effects of tailored health messages.
Because most studies on tailoring health risk informa-
tion were done for cancer screening, not much is
known about the effect for other decisions. More insight
is needed into why personalized risk messages might be
better understood and whether they are relevant for
other kinds of health decisions.
Formats for understanding outcomes over time
Choices of how to display long term outcomes to
improve understanding of risk are challenged by the diffi-
culty in obtaining accurate relevant long-term outcome
estimates of benefit and risk [84]. Randomized controlled
trials and systematic reviews usually represent a few
years of follow up at most. Yet to make an informed deci-
sion, patients and physicians are often interested in
longer term outcomes. Observational studies can provide
longer-term data but are prone to selection bias and con-
founding. An additional bias is the tendency for trials to
aggregate short and long term mortality which leads to
inaccurate estimates if hazard ratios are not constant
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over time [85]. These methodological problems are
beginning to be addressed by newer risk modeling
approaches [86-89].
When data are available, formats used to improve
patient understanding of outcomes over time include:
(a) the chance of a specific outcome at a single point in
the future; (b) chance of an outcome at multiple points
in the future; (c) mortality or survival graphs showing
risks over time; (d) cumulative future or lifetime chance
of an outcome; and (e) rate of occurrence of an out-
come that is likely constant over time.
Showing the chance of a specific outcome at a single
point in the future has the advantage of simplicity of pre-
sentation and calculation from available randomized
trials or cohort studies. Examples of this approach are
the 10 year risk of cardiovascular disease used in esti-
mates of risk and benefit of cholesterol medications [90]
and the risk in 3-5 years of precancerous changes on pap
smear or genital warts related to HPV vaccine [91]. This
method has also been used with multiple points in the
future. Examples include presenting the risk of having to
have repeat bypass surgery at 5 years and 10 years after
the initial procedure [92], and expected deaths after lung
transplantation for cystic fibroses shown at 1 month, 1
year, 3 years, 5 years, and 10 years [93].
Survival and mortality graphs are commonly used in
presenting research studies and have been used to relay
information to patients. However, patients’ interpretation
of these graphs may be susceptible to various biases.
When web-users were shown survival graphs for a
hypothetical disease and treatment, they based their per-
ceptions of treatment effectiveness on visual differences
in these graphs [94]. When a longer duration of data was
shown, people perceived larger differences in risk even
when the magnitude of risk reduction was identical.
Mortality graphs may be more temporally consistent
[95], but less well understood by patients [96]. Given
these findings and current limitations in evidence, a
balanced approach using both survival and mortality
graphs may be prudent until more information is avail-
able [97]. A study presenting treatment options for eso-
phageal cancer showed most patients understood
graphical representations of even complex multidimen-
sional patient-reported outcomes [98].
Another common format for representing outcomes
over time are estimates of the cumulative chance of an
event during a whole lifetime, although these can be dif-
ficult for people to understand [99]. Nevertheless, this
method is commonly used—e.g., in describing cancer
risk in patients with BRCA gene mutations [100]. People
are also often shown the cumulative chance of an event
over a certain period of time into the future (e.g., 10
years); for example osteoporosis treatment [101] and
hormone replacement therapy in menopause [102].
Cumulative risk over time is also used in PtDAs without
an explicit endpoint when describing probabilities
of outcomes after a specific event or intervention.
Examples include comparisons of outcomes of Achilles
tendon rupture with and without surgery [103], and of
cardiac resynchronization therapy in heart failure [104].
Rates are also used in conditions likely to have a rela-
tively constant risk over time. An example is birth con-
trol and the annual risk of pregnancy with a specific
method [105].
Although PtDAs providing quantitative risk informa-
tion have been shown to increase accuracy of risk per-
ceptions [26] and to promote knowledge and agreement
between values and choices [26], there are no trials
examining different formats for representing the risk of
outcomes over time.
Narrative methods for conveying the chance of an event
Individual patient narratives (i.e., stories of what one per-
son experienced or did, which are sometimes referred to
as “patient testimonials”) are sometimes provided in
PtDAs as a complement to statistical information about
risks. These stories can provide rich detail about what it is
like to experience a health condition or a particular out-
come of treatment. However, the provision of narratives
has been shown to influence perceived vaccination risk
and intentions [106]. In one study, narratives decreased
the perceived chance of adverse events but increased the
perceived severity of adverse events. Narratives also influ-
enced vaccination intention even after controlling for the
perception of vaccine riskiness. In the same study, the nat-
ure of the presented information (emotionality, richness)
was also varied to assess the impact on risk perception
and showed that the highly emotional narratives had a
greater impact on perceived risk although the richness of
the narratives did not.
Other studies have shown that patient testimonials
influence treatment choices. In one study, participants
receiving a disproportionate number of negative testi-
monials for surgery were less likely to choose surgery
compared to participants receiving equally positive and
negative examples for surgery [107]. In Ubel’s second
study, participants receiving no testimonials were most
likely to choose bypass surgery (58%), compared to
those receiving a proportionate number of testimonials
(37%) and those receiving a disproportionate number of
testimonials (34%). In this case, the testimonials signifi-
cantly reduced the choice of the most effective but inva-
sive and risky intervention.
Another study tested whether the use of a quiz or pic-
tograph lessened an individual’s reliance on anecdotal
evidence for angina treatment (bypass surgery or balloon
angioplasty) [53]. They found that, when statistical infor-
mation was reinforced with pictographs and quizzes,
anecdotes had no significant effect on treatment
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decisions. The same authors also found pictographs were
the active ingredient that lessened the effect of anecdotes.
This finding would argue for avoiding narratives without
statistical information.
In summary, using narratives to present benefit and
risk information may increase perceptions of risk sever-
ity, decrease the ability to accurately recall risk probabil-
ities, and influence treatment choice. The relative
number of narratives used can also influence decision
making. However, narratives vary in their purpose, con-
tent, and emotional balance[108], and some types of
narratives may be more or less likely to bias risk percep-
tions than others. For example, in principle, narratives
that report outcomes should influence likelihood per-
ceptions more than those which describe experiences or
decision processes [108]. Because of the potential that
narratives might have unintended effects on risk com-
munications, we suggest (a) that narratives should be
used with caution until research better clarifies their
effects, both positive and negative, and (b) that develo-
pers be more cautious about using narratives when
attempting to present unbiased information for
informed decision making than when attempting to be
persuasive and promote behaviour change. If narratives
are used to present benefit and risk information, they
should be accompanied by statistical information in pic-
tograph form. Graphical representations of risk may
reduce the effect of narratives. However, it seems likely
that information included in narratives is likely to influ-
ence the ways individuals either search for and/or pro-
cess information, which may make them either useful or
counterproductive when included in interventions
designed to facilitate good decision making.
Important skills for understanding numerical estimates
Numeracy is the ability to understand and apply mathema-
tical concepts. It can have considerable effect on the use
and interpretation of numerical estimates. Higher numer-
acy can facilitate computations, the interpretation of num-
bers, information seeking, depth of processing, memory for
numerical information, and trust in numerical formats,
leading to improved risk comparisons, risk estimates, and
value elicitations [33,109-113]. Lower numeracy is asso-
ciated with overestimation of risk probabilities [114,115],
higher susceptibility to factors other than numerical data (e.
g., framing, mood states, labels used to interpret quantita-
tive results and feedback from others) [33,116], insensitivity
to variations in risk magnitude (especially when multiple
numbers are shown at once) [117], and greater denomina-
tor neglect [64,118]. In particular, people with lower
numeracy are less likely to derive affective meaning from
numbers and are more influenced by affective considera-
tions from non-numerical aspects of the task [119].
Levels of numeracy in the general population are rela-
tively low. For example, a national survey showed that
one-quarter of the general US population cannot say
whether 1 in 10, 1 in 100, or 1 in 1000 represents the
largest risk of getting a disease; 30% cannot transform 20
in 100 to a percentage; 40% cannot say what is 1% out of
1000; and about 75% cannot transform 1 in 1000 to a
percentage [120]. Greater numeracy is associated with
higher education, younger age, and male gender
[109,110], although none of these characteristics guaran-
tee high numeracy. For example, even highly educated
people can be less numerate [121] and research has
demonstrated that numeracy can be more predictive of
comprehension and decisions than education and other
demographic variables [122-125].
Numeracy is relatively distinct from other aspects of
health literacy, general intelligence, and working mem-
ory [122,126,127] and can be acquired through instruc-
tion and deliberative practice [128]. Educational systems
that focus on mathematics and science education from
an early age may contribute to higher numeracy levels
in the general population [120,129]. Short interventions
aimed at improving patients’ numeracy and conse-
quently their risk understanding might be useful, but, at
present, research regarding the feasibility or efficacy of
such interventions is lacking.
Higher numeracy, however, does not preclude the need
for well-designed PtDAs. Patients need at least basic
numeracy but the communicators need to be aware of
and use an evidence-based approach to present informa-
tion in ways that are simple and clear. Even the highly
numerate can misunderstand inconsistent or difficult
information formats such as those involving unequal
denominators, unspecified reference classes, or condi-
tional probabilities. Furthermore, situational factors that
are often present in medical decision making, such as
time pressure and high levels of stress, can make the pro-
cessing of risk related information difficult even for
highly numerate people [109]. In addition, as individuals
age, their numeracy levels tend to decline [110,130]; this
is important because older adults tend to make a dispro-
portionate number of medical decisions relative to heal-
thier younger adult populations. Finally, more numerate
individuals may be more susceptible to some biases than
the less numerate (e.g., evaluating a possible gain as more
attractive when put into a context of a possible small loss
than when presented alone [116,131]. As a result, numer-
acy will usually help but sometimes may hinder patients’
abilities to use the most important dimensions in a deci-
sion. Unintended consequences of higher numeracy have
not been considered yet in health contexts, but, ulti-
mately, may be necessary to understand.
When designing a PtDA, understanding the abilities of
prospective users can help in designing presentation for-
mats that will maximize comprehension and use of impor-
tant information in PtDAs. For example, among those
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with lower numeracy and sufficient graph literacy, visual
displays can improve understanding [62,65,132,133]. A
number of measures of patients’ abilities relevant for
understanding of risks have been developed in recent
years (e.g., objective numeracy [121,134,126,135,136]; sub-
jective numeracy [137]; graph literacy [61]; other aspects
of the health literacy [138,139]. Unfortunately, with few
exceptions [71,111], studies of how numeracy and graph
literacy influence use and interpretation of numerical data
in PtDAs are lacking, and hence sorely needed. In the
absence of such data, it is difficult to assess whether tailor-
ing PtDAs to patient’s abilities would result in any
improved outcomes. Given that assessing patients’ numer-
acy and graph literacy in busy clinic settings may be diffi-
cult, it may be preferable to design PtDAs that benefit
patients across the whole continuum of abilities, and to
teach medical or other personnel to help patients make
sense of the information.
Interactive web-based formats
The increasing prevalence of computers, tablets, and
mobile devices creates new opportunities for interactive,
web-based formats for communicating probability infor-
mation. The literature in this area is sparse, and we are
aware of no published studies that have examined use of
such tools in actual PtDAs. Several experimental studies
suggest, however, that web-based formats offer both
opportunities and pitfalls. For example, in one study, parti-
cipants presented with a treatment scenario were better
calibrated in their perceptions of medication side effects
when they created a bar graph of the risk instead of just
viewing one [140]. Another study found that a web-based,
game-like, interactive risk graphic in which participants
clicked in a matrix until they uncovered a risk event had
the effect of reducing disparities in risk perceptions
between more and less numerate participants [141]. Such
exercises could be seen as methods to increase patients’
active processing of risk information, which may lead to
improved risk understanding. Indeed, the game-like inter-
active task elicited stronger emotional responses [40].
However, there are also considerable grounds for con-
cern about interactive risk graphics. In 2002, Tversky,
Morrison, and Betrancourt reviewed the literature on
animated graphics of all types and noted that “the
research on the efficacy of animated over static graphics
is not encouraging” [142]. More recently, research parti-
cipants who used an interactive pictograph applet to
visually graph provided risk numbers had significantly
worse knowledge and made poorer decisions than parti-
cipants who viewed static graphs [143].
Even without interactivity, animated graphics can use
motion cues to reinforce gist messages. However, the
evidence here is also mixed. One study found a dynamic
scattered icon display increased recipients’ subjective
uncertainty about a risk [39]. Another study tested
various types of animation in both grouped and scat-
tered icon displays and found that they failed to improve
participants’ ability to identify a dominant treatment
option and sometimes significantly impeded perfor-
mance [144].
In short, interactive web-based risk communication
formats allow educators to use additional cues in risk
communications. However, evidence is lacking to deter-
mine whether the techniques allowed by new technolo-
gies provide a net positive experience. Preliminary
evidence suggests that, unless the motion cues reinforce
the most critical gist message (e.g., the accumulation of
risk over time), there remains significant risk that inter-
active or animated formats may degrade knowledge ver-
sus evidence-based static formats.
Discussion
The science around risk communication is expanding
rapidly, and there is good evidence that patients have a bet-
ter understanding of risk if outcomes are presented as
numbers. Yet there is an emerging awareness that how risk
information is provided can improve people’s understand-
ing or bias their risk perceptions. We highlight in Table S1
(Additional file 1) our key messages regarding each of the
eleven major risk communication issues involved in the
presentation of probabilities and related risk information.
For example, it is increasingly clear that different for-
mats work better for different tasks, and PtDA develo-
pers should consider what cognitive tasks are required
for each decision. Our review also makes it clear that it
is important to include contextual information and to
consider the numeracy and graph literacy skills of the
PtDA users. Some format biases can be reduced by con-
current use of visual formats such as graphs and there
are some formats which should be avoided as they con-
sistently perform badly (e.g., “1 in x”).
This primer of risk communication for PtDA develo-
pers aims to provide a set of guiding principles based on
the current evidence-base in this field. However, one of
the challenges for PtDA developers is keeping up with
this rapidly changing evidence base. The ongoing com-
mitment to updates within the IPDAS Collaboration’s
standards development process is one promising way of
maintaining clear guidance regarding evidence-based
communication approaches, but the IPDAS Collabora-
tion faces the same sustainability challenges faced by
many other international collaborative groups: it is
always harder to keep a guidance document up to date
than it is to create one in the first place. Nevertheless, the
key approaches outlined in this paper should provide a
“roadmap” for good risk communication in PtDAs and,
indeed, in clinical practice more generally.
Given the fast pace of knowledge acquisition in this
area, it is often difficult to identify which practices are
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“best.” Yet, the same knowledge base is increasingly able
to identify communication practices which are known to
cause problems and biases. We urge all PtDA developers
and health practitioners who must communicate prob-
abilistic risk information to patients to become aware of
these adverse practices and to make sure they are not
carried forward simply because of familiarity or past use.
Our work has highlighted some important gaps in the
evidence base for risk communication, particularly in
tailoring information, formats for conveying outcomes
over time, conveying uncertainty, and the impact of
interactive web-based formats. Other under-developed
areas of research evidence include optimal formats for
people with lower numeracy and graph literacy, and risk
perceptions in different cultural contexts. Addressing
these needs will require not merely targeted research
efforts from selected investigators, but also a broad will-
ingness of PtDA developers to embed experimental tests
of different communication designs in their products.
Only through a process of systematic, widespread inves-
tigation of risk communication methods and broad dis-
semination of the subsequent results can we hope to
ensure that future PtDAs will present probabilistic infor-
mation to patients in ways that are truly meaningful and
useful to them as they make their medical decisions.
Conclusion
Presenting numeric outcomes of decisions is an impor-
tant component of good PtDA design and improves
patients’ accuracy of risk perception. Good evidence
exists for strategies that can improve risk communica-
tion. Our guiding principles for numeric estimates aim to
assist PtDA developers to create better tools for informed
decision making. Adherence to the basic principles out-
lined herein should be considered a quality standard for
PtDAs and related risk communication materials.
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